Article Details

Dyno Therapeutics Strikes AAV Deal with Roche Worth up to $1.8 Billion

Retrieved on: 2020-10-13 22:03:16

Tags for this article:

Click the tags to see associated articles and topics

Dyno Therapeutics Strikes AAV Deal with Roche Worth up to $1.8 Billion. View article details on hiswai:

Excerpt

<div><b>Roche</b> and its subsidiary Spark Therapeutics, which it acquired in 2019 for $4.8 billion, will take the capsids and conduct preclinical studies with hopes ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up